AI assistant
DEXCOM INC — Director's Dealing 2017
Feb 13, 2017
30198_dirs_2017-02-13_163d1a70-7049-4c34-a264-84b09d4227f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2017-02-09
Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-09 | Common Stock | D | 1421 | $79.35 | Disposed | 439845 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11461 | Indirect |
| Common Stock | 55882 | Indirect |
Footnotes
F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
F2: Included in this number are 39,079 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 5,079 unvested restricted stock units granted on March 8, 2014 and shall vest on March 8, 2017.
F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.